Mitomycin is used extensively for the prevention of recurrence of supe
rficial bladder cancer. Most treatment regimens of mitomycin are long
term, since this seems more effective in preventing recurrence. During
treatment some patients develop cystitis of variable severity, which
may lead to mucosal ulcerations and cessation of treatment. We report
a case in which long-term treatment with mitomycin, following a single
episode of transitional cell bladder cancer, has led to bladder fibro
sis and loss of its function, without evidence of tumor recurrence.